Leber Congenital Amaurosis.

Area of Science:

• Ophthalmology
• Genetics
• Pediatric Medicine

Background:

• Leber congenital amaurosis (LCA) is a severe form of early-onset retinal dystrophy (EORD).
• It presents in infancy, affecting approximately 1 in 80,000 newborns.
• LCA is characterized by significant vision impairment from birth, often accompanied by nystagmus.

Purpose of the Study:

• To summarize the key clinical features and genetic underpinnings of Leber congenital amaurosis (LCA).
• To describe the typical presentation, diagnostic indicators, and disease progression associated with LCA.
• To highlight the variability in clinical course based on specific genetic mutations.

Main Methods:

• Review of existing literature on Leber congenital amaurosis (LCA).
• Analysis of clinical data including visual acuity, fundus examination, and electroretinography (ERG).
• Correlation of genotype with phenotype, examining mutations in genes such as GUCY2D, RPE65, AIPL1, CRB1, CEP290, and NMNAT1.

Main Results:

• LCA patients exhibit profound vision loss (no light perception to 20/400), nystagmus, and absent pupillary reflexes.
• Fundus findings may initially be normal, progressing to pigmentary disturbances; keratoconus and oculodigital reflex are associated features.
• Electroretinography (ERG) responses are typically undetectable.
• Genetic mutations dictate disease progression: GUCY2D mutations lead to a stable course, RPE65 mutations show initial improvement then deterioration, and others like AIPL1, CRB1, CEP290, NMNAT1 cause gradual decline over decades.

Conclusions:

• Leber congenital amaurosis (LCA) is a genetically heterogeneous condition with diverse clinical trajectories.
• Understanding the specific gene mutation is crucial for predicting disease progression and potential management strategies.
• Early diagnosis and genetic analysis are vital for managing LCA and its associated complications, including potential intellectual disability.